Microbiology is a scientific study dealing with microorganisms (bacteria, viruses, fungi, etc.) and examining their influence on the other living organisms. The industrial microbiology canvasses the use of microorganisms in the manufacture of various goods such as food products, enzymes, beverages, chemical raw materials, pharmaceuticals as well as in the development of special technologies for pollution control and waste treatment. Currently, the microbiology industry is also engaged in the production of immunomodulating compounds, monoclonal antibodies and complex plant metabolites. Microbiology devices are used in almost all industries.
Virology is a subdivision of microbiology which focuses on the study of different viruses, their evolution and classification criteria. Viral infectious diseases fall within the scope of the virology. They include but are not limited to rabies, herpes, rhinoviruses, human papillomavirus, influenza, AIDS, measles, etc.
The research reports found in this MarketPublishers’ catalogue disclose trends in the microbiology and virology market. The researches provide access to information on the key market indicators and characterize major forces shaping the market. The reports market statistics and reveal the market potential. A clear picture of the present state of the market, profiles of the top market participants and analyses of market drivers and restrains are available in the researches. Moreover, the future opportunities for the microbiology and virology market are covered in the research reports.
Publications found:
818
Sort by:
Molecular Biology Enzymes & Kits & Reagents Market by Product (Kit, Reagent, Enzyme), Application (PCR, Sequencing, Epigenetic, Synthetic Biology), End user (Research Institutes, Pharma & Biotech Company, Hospitals) and Region - Global Forecast to 2026
US$ 4,950.00
“The molecular biology enzymes and kits & reagents market projected to grow at a CAGR of 15.8%.” The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 billion by 2022 from USD ...
May 2021
266 pages
Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Size study, by Product (Instruments, Reagent, Services), by Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), by Application (Streptococcus, Clostridium Difficile, Carbapenem-resistant enterobacterial testing (CRE), Respiratory virus, Tuberculosis (TB) & drug-resistant TB, Human Immunodeficiency Virus (HIV), Gonorrhea, Chlamydia, Others), by End-Use (Point of Care, Central Laboratories, Others) and Regional Forecasts 2020-2027
US$ 4,950.00
Global Infectious Diseases in-Vitro Diagnostics (IVD) Market is valued at approximately USD 54 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.8% over the forecast...
March 2021
200 pages
